Highly Sensitive Conjugates for Western Blots Now Available on Labscoop
Little Rock, AR, August 12, 2015 (Newswire.com) - Jackson ImmunoResearch Laboratories, Inc. (JIR), a leader in the production and conjugation of affinity-purified secondary antibodies and purified immunoglobulins, is now listing over 4000 products on the Labscoop platform. JIR products are sold primarily to scientists in universities and research institutes throughout the world who are conducting research in the plant, animal, and biomedical sciences. “Jackson ImmunoResearch Laboratories recently celebrated our 34th year of providing exceptional reagents for our research customers.” said Dr. William J. Stegeman, CEO of JIR, “We are excited to be a part of this innovative platform to reach the next generation of researchers and scientists.” The JIR product line joins an already impressive line-up of nearly 5,000,000 products available on Labscoop.
About Jackson ImmunoResearch Laboratories, Inc.:
"Jackson ImmunoResearch Laboratories recently celebrated our 34th year of providing exceptional reagents for our research customers." said Dr. William J. Stegeman, CEO of JIR, "We are excited to be a part of this innovative platform to reach the next generation of researchers and scientists."
Dr. William J. Stegeman, CEO
JIR is located in rural Pennsylvania, near the Amish country, about 40 miles west of Philadelphia. It was started in 1982 by scientists whose education and previous experience included research in cell biology, protein chemistry, microbiology, and product development in immunology.
About Labscoop:
Labscoop was founded in early January 2014, set on a path that will fundamentally change the way scientists shop for lab reagents, consumables, and equipment. Our company strives to create an amazing user experience for scientists with in-depth product peer reviews, comprehensive product specifications and associated data files that will allows scientists to quickly and easily search, compare and order products thus simplifying the lab procurement process. (Watch the video)
CONTACT:
Public Relations